中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2014年
11期
18-19
,共2页
李坤%郎卫华%王志学%冀向宁%刘玉青
李坤%郎衛華%王誌學%冀嚮寧%劉玉青
리곤%랑위화%왕지학%기향저%류옥청
神经生长因子%前部缺血性视神经病变
神經生長因子%前部缺血性視神經病變
신경생장인자%전부결혈성시신경병변
Nerve-growth-factor%Anterior-ischemic-optic-neuropathy
目的:观察前部缺血性视神经病变的临床疗效。方法:选取前部缺血性视神经病变患者34例为研究对象。全部患者均进行综合治疗,随访治疗效果。结果:治疗后患者眼底检查改善率97.1%;矫正视力明显提高,差异具有统计学意义(t 值=7.5722,P<0.01);光敏感度明显提高,差异具有统计学意义(P<0.01);患者视野缺损明显降低,差异具有显著统计学意义(P<0.01);患者视神经纤维层厚度明显降低,差异具有统计学意义(P<0.05)。结论:采取常规治疗结合神经生长因子用于前部缺血性视神经病变的治疗效果显著,能够显著改善视力,提高视野光敏度,降低视野缺损,降低视神经纤维层厚度损伤。
目的:觀察前部缺血性視神經病變的臨床療效。方法:選取前部缺血性視神經病變患者34例為研究對象。全部患者均進行綜閤治療,隨訪治療效果。結果:治療後患者眼底檢查改善率97.1%;矯正視力明顯提高,差異具有統計學意義(t 值=7.5722,P<0.01);光敏感度明顯提高,差異具有統計學意義(P<0.01);患者視野缺損明顯降低,差異具有顯著統計學意義(P<0.01);患者視神經纖維層厚度明顯降低,差異具有統計學意義(P<0.05)。結論:採取常規治療結閤神經生長因子用于前部缺血性視神經病變的治療效果顯著,能夠顯著改善視力,提高視野光敏度,降低視野缺損,降低視神經纖維層厚度損傷。
목적:관찰전부결혈성시신경병변적림상료효。방법:선취전부결혈성시신경병변환자34례위연구대상。전부환자균진행종합치료,수방치료효과。결과:치료후환자안저검사개선솔97.1%;교정시력명현제고,차이구유통계학의의(t 치=7.5722,P<0.01);광민감도명현제고,차이구유통계학의의(P<0.01);환자시야결손명현강저,차이구유현저통계학의의(P<0.01);환자시신경섬유층후도명현강저,차이구유통계학의의(P<0.05)。결론:채취상규치료결합신경생장인자용우전부결혈성시신경병변적치료효과현저,능구현저개선시력,제고시야광민도,강저시야결손,강저시신경섬유층후도손상。
Objective:To observe the clinical curative effects of anterior ischemic optic neuropathy. Methods:34 cases with anterior ischemic optic neuropathy were used as the research objects, given the comprehensive treatment, and then followed up to ob-serve therapeutic effects. Results: The improvement rate of the patients through the fundus inspection was 97. 1% . The corrected visual acuity was improved obviously, and the difference was statistically significant (t=7. 7522, P<0. 05). The average light sensitivity was improved obviously, and the difference had the significant statistical significance (P<0. 01). The average visual defect was significant-ly reduced, and the difference had the significant statistical significance (P<0. 01). The optic nerve fiber layer thickness was signifi-cantly reduced, and the difference had the statistical significance (P<0. 05). Conclusions: The conventional treatment combined with nerve growth factor for the treatment of anterior ischemic optic neuropathy has a significant effect, can significantly improve the vision, improve the light sensitivity, reduce the visual defect, and reduce the defected optic nerve fiber layer thickness.